SELLAS Life Sciences (SLS) Receivables - Other (2012 - 2018)

SELLAS Life Sciences (SLS) has 5 years of Receivables - Other data on file, last reported at $6.6 million in Q3 2018.

• Receivables - Other for Q3 2018 came in at $6.6 million, up 1220.0% year-over-year; the trailing twelve-month figure through Sep 2018 was $6.6 million (up 1220.0% YoY), and the FY2015 annual result was $21.7 million, changed N/A from the prior year.
• Receivables - Other advanced to $6.6 million in Q3 2018 per SLS's latest filing, from $500000.0 in the prior quarter.
• Over five years, Receivables - Other peaked at $21.7 million in Q4 2015 and troughed at $500000.0 in Q3 2017.
• A 4-year average of $7.6 million and a median of $4.1 million in 2016 frame the typical range for Receivables - Other.
• On a YoY basis, Receivables - Other climbed as much as 1220.0% in 2018 and fell as far as 1220.0% in 2018.
• A 4-year view of Receivables - Other shows it stood at $21.7 million in 2015, then sank by 92.17% to $1.7 million in 2016, then tumbled by 70.59% to $500000.0 in 2017, then jumped by 1220.0% to $6.6 million in 2018.
• Business Quant data shows SLS's Receivables - Other at $6.6 million in Q3 2018, $500000.0 in Q3 2017, and $1.7 million in Q1 2016.